TOMSK, Jun 10 – RIA Tomsk. Tomsk State University of Control Systems and Radioelectronics (TUSUR) and Novosibirsk State University
(NSU) with the assistance of the Kama Flow company created the Russia's first
intercollegiate fund which will allow to select and bring perspective
developments to the market, the TUSUR press service reported on Friday.
"One of the key
objectives of the fund – is carrying out examinations which will allow to estimate
prospects of idea, to define the potential market, to analyse possibilities of
its realization. <…> TUSUR and NSU are provided projects, will organize
scientific examination, Kama Flow will carry out economic, marketing expertize,
help to define strategy of development of the project, to attract
investments", – is said in the message.
It is specified that the
projects which passed preliminary expert examination will get financial support
for further development. Now selection of projects for preliminary expert
examination is conducted.
© сайт ТУСУРа
It is noted that there is a
set of similar organizations in Russia, however venture fund of TUSUR, NSU and
Kama Flow – the first one, created not by one, but several higher education
institutions. At the same time the existing funds are focused on concrete
startups at various stages, but it is difficult to scientist to understand,
whether the idea worth investing in it and in what direction it can be
developed – only experts can answer these questions.
"The university is the
center of science, education and innovations now. It is very important that
developments of scientists didn't remain on paper, and were demanded by the
industry, were realized, became a basis for the new innovative
enterprises", – are quoted in the message words of the TUSUR vice rector
on scientific work and innovations Roman Meshcheryakov.
KamaFlow – is Moscow company
which helps developers innovators to develop their projects, attracting
investments, experts and other necessary resources. The profile areas of work
are IT, Internet technologies, industrial and biomedical innovations.